Grant of share options and Directors' dealings

RNS Number : 9836P

e-Therapeutics plc

23 November 2016

 

23 November 2016

e-Therapeutics plc

('e-Therapeutics' or 'the Company')

Grant of share options and Directors' dealings

Oxford and Newcastle, UK, 23 November 2016 - e-Therapeutics plc (AIM: ETX) the drug discovery company, announces that on 23 November 2016 the Company granted options over a total of 10,310,000 ordinary shares of 0.1p each to certain executive directors and other employees (the "Optionholders"). The Optionholders are entitled to exercise their options in three tranches (as set out below) on or after the date specified below, if, at the time of exercise, the prevailing market price of the Company's ordinary shares is not less than the price set out below (the "Exercise Price"). Optionholders will be required to pay the Exercise Price to exercise their options. 

Number of shares under option             Exercise Price             Exercise Date

3,436,666                                              16.76p                          23 November 2018

3,436,667                                              20.95p                          23 November 2018

3,436,667                                              25.14p                          23 November 2019

Details of the individual options granted to executive directors are set out below:

Director                                     Number of shares under option

Steve Medlicott                          2,000,000

Sean Nicolson                           750,000

The options referred to above are otherwise subject to the Rules of the Company's 2013 Performance Share Plan. 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Steve Medlicott
2	Reason for notification
a.	Position/Status	Director
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	e-Therapeutics plc
b.	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary shares of 0.1p each   ISIN: GB00B2823H99
b.	Nature of the transaction	Grant of options to subscribe for ordinary shares
c.	Price(s) and volume(s)
			Exercise price(s)	Volume(s)
			£0.1676	666,666
			£0.2095	666,667
			£0.2514	666,667
d.	Aggregated information- Aggregated Volume - Price	Volume: 2,000,000 options over ordinary shares Price:  N/A
e.	Date of the transaction	23 November 2016
f.	Place of the transaction	London Stock Exchange

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Sean Nicolson
2	Reason for notification
a.	Position/Status	Director
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	e-Therapeutics plc
b.	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary shares of 0.1p each   ISIN: GB00B2823H99
b.	Nature of the transaction	Grant of options to subscribe for ordinary shares
c.	Price(s) and volume(s)
			Exercise Price(s)	Volume(s)
			£0.1676	250,000
			£0.2095	250,000
			£0.2514	250,000
d.	Aggregated information- Aggregated Volume - Price	Volume: 750,000 Price:  N/A
e.	Date of the transaction	23 November 2016
f.	Place of the transaction	London Stock Exchange

 

END

 

 

DSHLLFLRLTLVFIR